Clinical trial
Paclitaxel + Trastuzumab + Pertuzumab as Pre-Op for Inflammatory BrCa
NCT01796197
Study timeline
Study start (actual)2013-08-01Date precision: month
Registry last updated2026-02-05
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
TrastuzumabDRUG · verified · RxNorm: trastuzumab
PertuzumabDRUG · verified · RxNorm: pertuzumab
PaclitaxelDRUG · verified · RxNorm: paclitaxel
DoxorubicinDRUG · verified · RxNorm: doxorubicin
CyclophosphamideDRUG · verified · RxNorm: cyclophosphamide
MastectomyPROCEDURE
Radiation TherapyRADIATION
Sponsors & collaborators
Dana-Farber Cancer Institutelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01796197 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.